Skip to main content
. 2019 Aug;81(3):415–425. doi: 10.18999/nagjms.81.3.415

Table 2.

Patient characteristics

Watering eyes (n=6) No watering eyes (n=5) p
Median (Range) Median (Range)
Age (year) 70 (44–80) 63 (43–67) 0.297a
Sex (male/female) 6 (3/3) 5 (3/2) 1.000b
Height (cm) 156.15 (147.0–178.0) 156.2 (154.3–164.0) 0.535a
Body weight (kg) 46.75 (40.0–58.8) 47.6 (31.2–78.4) 0.548a
Body surface area (m2) 1.372 (1.29–1.69) 1.404 (1.16–1.79) 0.548a
Serum creatinine (mg/dL) 0.61 (0.43–0.98) 0.6 (0.47–0.8) 0.575a
Initial dose (mg) 100 (80–120) 100 (80–120) 0.535a
Total dose (mg) 13,440 (4,880–19,790) 13,440 (5,820–22,360) 0.548a
Relative dose intensity (%) 85.13 (49.11–99.41) 79.95 (54.34–95.14) 0.522a
Treatment period (course) 6.5 (2–8) 8 (2–8) 0.382a
Treatment period (days) 319 (84–350) 350 (91–371) 0.601a

Relative dose intensity = actual dose (mg) / standard dose (mg)

a Mann-Whitney U-test, b Fisher exact probability